scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.CIR.0000021923.58307.8F |
P698 | PubMed publication ID | 12093763 |
P2093 | author name string | Jonathan A Epstein | |
Min Min Lu | |||
Ruchira Glaser | |||
Navneet Narula | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 17-19 | |
P577 | publication date | 2002-07-01 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts | |
P478 | volume | 106 |
Q36543846 | 7. Transplantation of undifferentiated, bone marrow-derived stem cells |
Q29620122 | Adult cardiac stem cells are multipotent and support myocardial regeneration |
Q35006436 | Adult stem cells: assessing the case for pluripotency |
Q35648369 | Allograft arteriopathy: pathogenesis update |
Q28198165 | An overview of stem cell research and regulatory issues |
Q35456617 | Association of CD14+ monocyte-derived progenitor cells with cardiac allograft vasculopathy |
Q46736510 | Bone marrow-derived recipient cells in murine transplanted hearts: potential roles and the effect of immunosuppression |
Q36349782 | Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction |
Q38336874 | Cardiac regeneration in children |
Q37182776 | Cardiac stem cells and progenitors: developmental biology and therapeutic challenges. |
Q36603788 | Cardiac stem cells: A promising treatment option for heart failure |
Q35184048 | Cardiac tissue engineering for replacement therapy |
Q36667275 | Cell-based approaches for cardiac repair |
Q37186905 | Characteristics of cardiac allograft vasculopathy induced by immunomodulation in the miniature Swine |
Q35791966 | Chimera analysis supports a predominant role of PDGFRbeta in promoting smooth-muscle cell chemotaxis after arterial injury |
Q54561747 | Chimerism and microchimerism of the human heart: evidence for cardiac regeneration. |
Q33209554 | Chimerism of metanephric adenoma but not of carcinoma in kidney transplants |
Q45919870 | Contribution of pre-existing vascular disease to allograft vasculopathy in a murine model. |
Q27301448 | Contribution of recipient-derived cells in allograft neointima formation and the response to stent implantation |
Q30439134 | Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. |
Q44398652 | Converging pathways and principles in heart development and disease: CV@CSH. |
Q35623878 | Current status of stem cell therapy in heart failure |
Q34617338 | Diabetes and aging alter bone marrow contributions to tissue maintenance |
Q36853973 | Dissecting the molecular relationship among various cardiogenic progenitor cells |
Q82662237 | Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans |
Q37402084 | Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation |
Q38058477 | Endothelial dysfunction and cardiac allograft vasculopathy |
Q35541459 | Hope for a broken heart? |
Q46425493 | Impairment of recipient cytolytic activity attenuates allograft vasculopathy |
Q37120197 | Increased cardiac myocyte progenitors in failing human hearts |
Q36482254 | Insights into the role of focal adhesion modulation in myogenic differentiation of human mesenchymal stem cells |
Q73904392 | Little evidence for cell fusion between recipient and donor-derived cells |
Q30433459 | Lost in transdifferentiation. |
Q38194688 | Macrophages in solid organ transplantation |
Q91950849 | Major Histocompatibility Complex-Matched Arteries Have Similar Patency to Autologous Arteries in a Mauritian Cynomolgus Macaque Major Histocompatibility Complex-Defined Transplant Model |
Q28205052 | Mechanisms and consequences of somatic mosaicism in humans |
Q37296154 | Metabolic modulation and cellular therapy of cardiac dysfunction and failure |
Q30481132 | Mouse models of arteriosclerosis: from arterial injuries to vascular grafts |
Q79868993 | Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin |
Q57176905 | New Myocyte Formation in the Adult Heart: Endogenous Sources and Therapeutic Implications |
Q36749464 | New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy. |
Q34389370 | Patterns of myocardial histogenesis as revealed by mouse chimeras |
Q47611450 | Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart |
Q31141231 | Physiological Coupling of Donor and Host Cardiomyocytes After Cellular Transplantation |
Q37053167 | Progenitor cells and vascular disease |
Q22251075 | Regenerating the heart |
Q35749921 | Regenerative capacity of the myocardium: implications for treatment of heart failure |
Q33408356 | Role of endogenous bone marrow cells in long-term repair mechanisms after myocardial infarction |
Q34960327 | Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation |
Q37045472 | Stem cell differentiation: cardiac repair |
Q35095437 | Stem cell origins of intimal cells in graft arterial disease |
Q35661000 | Stem cell plasticity: from transdifferentiation to macrophage fusion. |
Q34315088 | Stem cell treatment of the heart: a review of its current status on the brink of clinical experimentation |
Q35192887 | Stem cells and cardiovascular disease |
Q35832759 | Stem cells and repair of the heart. |
Q36446920 | Stem cells for the ischaemic heart |
Q37183624 | Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies. |
Q36197188 | Stem cells of the alveolar epithelium |
Q35104920 | Stem-cell “plasticity”: befuddled by the muddle |
Q37625460 | The existence of myocardial repair: mechanistic insights and enhancements |
Q42252887 | The human heart: a self-renewing organ |
Q37625948 | Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle. |
Search more.